Payden & Rygel’s Amdocs DOX Stock Holding History

Payden & Rygel’s Portfolio DOX Stock Details DOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-216,300	Closed	-$18.3M	–	139
2023 Q3	$18.3M	Sell	216,300 -47,000	-18%	-$4.25M	1.25%	22
2023 Q2	$26M	Sell	263,300 -125,700	-32%	-$11.8M	1.84%	10
2023 Q1	$37.4M	Buy	+389,000	New	+$36M	2.21%	6
2022 Q4	–	Sell	-288,800	Closed	-$22.9M	–	137
2022 Q3	$22.9M	Buy	288,800 +118,100	+69%	+$10M	1.34%	32
2022 Q2	$14.2M	Buy	+170,700	New	+$14.1M	0.85%	59

Other funds holding DOX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Payden & Rygel's DOX Position: Q4 2023 in Review

Payden & Rygel sold out of Amdocs (DOX) in Q4 2023, closing a stake of 216,300 shares — an estimated $18.3M sold.

Payden & Rygel first reported a position in DOX in Q2 2022 and held it in 5 quarters. The position peaked at $37.4M in Q1 2023. 509 funds tracked by Wall St. Rank hold DOX as of Q4 2023.

Payden & Rygel reported no remaining Amdocs position as of Q4 2023 after selling out during the quarter.
Payden & Rygel sold 216,300 Amdocs shares in Q4 2023, an estimated $18.3M.
Payden & Rygel first reported a position in Amdocs in Q2 2022 and held it in 5 quarters.
Payden & Rygel's Amdocs position peaked at $37.4M in Q1 2023.
509 funds tracked by Wall St. Rank held Amdocs as of Q4 2023.

Based on Payden & Rygel's 13F filing for Q4 2023, filed 13 Feb 2024.